{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:45:52Z","timestamp":1785386752714,"version":"3.55.0"},"reference-count":79,"publisher":"The Company of Biologists","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"am","delay-in-days":1598,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["NGFNplus Parkinson Net"],"award-info":[{"award-number":["NGFNplus Parkinson Net"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["Project 8.2.7"],"award-info":[{"award-number":["Project 8.2.7"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GI 342\/3-1"],"award-info":[{"award-number":["GI 342\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Suna and Inan K\u0131ra\u00e7 Foundation; Bo\u011fazi\u00e7i University"},{"name":"International Parkinson Fonds"},{"DOI":"10.13039\/501100003493","name":"Hertie Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003493","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Parkinson's disease (PD) is a frequent neurodegenerative process at old age. Accumulation and aggregation of the lipid-binding SNARE complex component alpha-synuclein (SNCA) underlies this vulnerability and defines stages of disease progression. Determinants of SNCA levels and mechanisms of SNCA neurotoxicity are intensely investigated. In view of physiological SNCA roles in blood to modulate vesicle release, we studied blood samples from a new large pedigree with SNCA gene duplication (PARK4 mutation), to identify effects of SNCA gain-of-function as potential disease biomarkers. The expression of other Parkinson's disease gene was not, but complexin-1 (CPLX1) mRNA downregulation was correlated with genotype. In global RNAseq profiling of blood from presymptomatic PARK4, bioinformatics detected significant upregulations for platelet activation, hemostasis, lipoproteins, endocytosis, lysosome, cytokine, toll like receptor signalling and extracellular pathways. In PARK4 platelets, stimulus-triggered degranulation was impaired. Strong SPP1, GZMH, and PLTP mRNA upregulations were validated in PARK4. When analysing cases with REM sleep behaviour disorder (RBD), the most specific known prodromal stage of general PD, only blood CPLX1 levels were altered. Validation experiments confirmed an inverse mutual regulation of SNCA and CPLX1 mRNA levels. In the 3\u2032-UTR of the CPLX1 gene we identified a SNP that is significantly associated with PD risk. In summary, our data define CPLX1 as PD risk factor and provide functional insights into the role and regulation of blood alpha-synuclein levels. The novel blood biomarkers of PARK4 in this Turkish family may become useful for PD prediction.<\/jats:p>","DOI":"10.1242\/dmm.028035","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T02:10:21Z","timestamp":1484964621000},"source":"Crossref","is-referenced-by-count":15,"title":["Blood RNA biomarkers in prodromal PARK4 and REM sleep behavior disorder show role of complexin-1 loss for risk of Parkinson's disease"],"prefix":"10.1242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-6825","authenticated-orcid":false,"given":"Suna","family":"Lahut","sequence":"first","affiliation":[{"name":"Exp. Neurology, Goethe University Medical School, 60590 Frankfurt\/Main, Germany"},{"name":"NDAL, Bo\u011fazi\u00e7i University, 34342 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Gispert","sequence":"additional","affiliation":[{"name":"Exp. Neurology, Goethe University Medical School, 60590 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcr","family":"\u00d6m\u00fcr","sequence":"additional","affiliation":[{"name":"Exp. Neurology, Goethe University Medical School, 60590 Frankfurt\/Main, Germany"},{"name":"NDAL, Bo\u011fazi\u00e7i University, 34342 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candan","family":"Depboylu","sequence":"additional","affiliation":[{"name":"Dept. of Neurology, Philipps University, Baldingerstrasse, 35043 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Seidel","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Chronomedical Institute, Goethe University, 60590 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Antolio","family":"Dom\u00ednguez-Bautista","sequence":"additional","affiliation":[{"name":"Exp. Neurology, Goethe University Medical School, 60590 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Brehm","sequence":"additional","affiliation":[{"name":"Exp. Neurology, Goethe University Medical School, 60590 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1830-514X","authenticated-orcid":false,"given":"H\u00fclya","family":"Tireli","sequence":"additional","affiliation":[{"name":"Dept. of Neurology, Haydarpa\u015fa Numune Training and Research Hospital, 34668 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Hackmann","sequence":"additional","affiliation":[{"name":"Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstrasse 74, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7958-631X","authenticated-orcid":false,"given":"Caroline","family":"Pirkevi","sequence":"additional","affiliation":[{"name":"NDAL, Bo\u011fazi\u00e7i University, 34342 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Leube","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Heinrich Heine University, 40225 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ries","sequence":"additional","affiliation":[{"name":"Dept. of Neurology, Philipps University, Baldingerstrasse, 35043 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Reim","sequence":"additional","affiliation":[{"name":"Dept. of Molecular Neurobiology and Center for the Molecular Physiology of the Brain, Max Planck Institute of Experimental Medicine, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Brose","sequence":"additional","affiliation":[{"name":"Dept. of Molecular Neurobiology and Center for the Molecular Physiology of the Brain, Max Planck Institute of Experimental Medicine, 37075 G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred F.","family":"den Dunnen","sequence":"additional","affiliation":[{"name":"Dept. of Pathology and Medical Biology, Medical Center, University, 9700 RB Groningen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madrid","family":"Johnson","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Biophysik and Frankfurt Institute for Molecular Life Sciences, Goethe University, 60438 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2682-7340","authenticated-orcid":false,"given":"Zsuzsanna","family":"Wolf","sequence":"additional","affiliation":[{"name":"Hemophilia Centre, Medical Clinic III, Institute of Transfusion Medicine and Immunhematology Goethe University, 60590 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schindewolf","sequence":"additional","affiliation":[{"name":"Dept. of Internal Medicine, Division of Vascular Medicine and Hemostaseology, Goethe University, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Schrempf","sequence":"additional","affiliation":[{"name":"Division of Neurodegenerative Diseases, Dept. of Neurology, Technische Universit\u00e4t, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Reetz","sequence":"additional","affiliation":[{"name":"Dept. of Neurology, RWTH Aachen University Hospital, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Young","sequence":"additional","affiliation":[{"name":"Dept. of Sleep Medicine and Neuromuscular Disorders, University Hospital M\u00fcnster, 48149 M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vadasz","sequence":"additional","affiliation":[{"name":"Dept. of Neurology, Philipps University, Baldingerstrasse, 35043 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilleas S.","family":"Frangakis","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Biophysik and Frankfurt Institute for Molecular Life Sciences, Goethe University, 60438 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin","family":"Schr\u00f6ck","sequence":"additional","affiliation":[{"name":"Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstrasse 74, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmuth","family":"Steinmetz","sequence":"additional","affiliation":[{"name":"Exp. Neurology, Goethe University Medical School, 60590 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Jendrach","sequence":"additional","affiliation":[{"name":"Exp. Neurology, Goethe University Medical School, 60590 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"R\u00fcb","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Chronomedical Institute, Goethe University, 60590 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe Nazl\u0131","family":"Ba\u015fak","sequence":"additional","affiliation":[{"name":"NDAL, Bo\u011fazi\u00e7i University, 34342 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Oertel","sequence":"additional","affiliation":[{"name":"Dept. of Neurology, Philipps University, Baldingerstrasse, 35043 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7355-2701","authenticated-orcid":false,"given":"Georg","family":"Auburger","sequence":"additional","affiliation":[{"name":"Exp. Neurology, Goethe University Medical School, 60590 Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2017,1,1]]},"reference":[{"key":"2021042500132194700_DMM028035C1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbalip.2011.06.013","article-title":"Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism","volume":"1821","author":"Albers","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"2021042500132194700_DMM028035C2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"2021042500132194700_DMM028035C3","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1002\/pmic.200400848","article-title":"Proteome analysis of human substantia nigra in Parkinson's disease","volume":"4","author":"Basso","year":"2004","journal-title":"Proteomics"},{"key":"2021042500132194700_DMM028035C4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jns.2007.10.012","article-title":"Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation","volume":"267","author":"Battisti","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"2021042500132194700_DMM028035C5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.sleep.2012.10.015","article-title":"Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder","volume":"14","author":"Boeve","year":"2013","journal-title":"Sleep Med."},{"key":"2021042500132194700_DMM028035C6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"2021042500132194700_DMM028035C7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3233\/JPD-150606","article-title":"Age-related changes of 14-3-3 isoforms in midbrain of A53T-SNCA overexpressing mice","volume":"5","author":"Brehm","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"2021042500132194700_DMM028035C8","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s12035-014-8911-6","article-title":"A genetic mouse model of Parkinson's disease shows involuntary movements and increased postsynaptic sensitivity to apomorphine","volume":"52","author":"Brehm","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"2021042500132194700_DMM028035C9","doi-asserted-by":"publisher","first-page":"14966","DOI":"10.1073\/pnas.0406283101","article-title":"Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions","volume":"101","author":"Chandra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042500132194700_DMM028035C10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","article-title":"What genetics tells us about the causes and mechanisms of Parkinson's disease","volume":"91","author":"Corti","year":"2011","journal-title":"Physiol. Rev."},{"key":"2021042500132194700_DMM028035C11","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/jnc.12497","article-title":"Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells","volume":"128","author":"Crabtree","year":"2014","journal-title":"J. Neurochem."},{"key":"2021042500132194700_DMM028035C12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mds.21223","article-title":"The ups and downs of alpha-synuclein mRNA expression","volume":"22","author":"D\u00e4chsel","year":"2007","journal-title":"Mov. Disord."},{"key":"2021042500132194700_DMM028035C13","doi-asserted-by":"publisher","first-page":"e00592","DOI":"10.7554\/eLife.00592","article-title":"Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2\/VAMP2","volume":"2","author":"Diao","year":"2013","journal-title":"Elife"},{"key":"2021042500132194700_DMM028035C14","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1002\/jnr.22137","article-title":"Phospholipid transfer protein reduces phosphorylation of tau in human neuronal cells","volume":"87","author":"Dong","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"2021042500132194700_DMM028035C15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12920-016-0164-y","article-title":"Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease","volume":"9","author":"Dumitriu","year":"2016","journal-title":"BMC Med. Genomics"},{"key":"2021042500132194700_DMM028035C16","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1093\/brain\/awu291","article-title":"Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation","volume":"137","author":"Fishbein","year":"2014","journal-title":"Brain"},{"key":"2021042500132194700_DMM028035C17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","article-title":"Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication","volume":"68","author":"Fuchs","year":"2007","journal-title":"Neurology"},{"key":"2021042500132194700_DMM028035C18","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/brain\/awq132","article-title":"SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease","volume":"133","author":"Garcia-Reitbock","year":"2010","journal-title":"Brain"},{"key":"2021042500132194700_DMM028035C19","doi-asserted-by":"publisher","first-page":"e71634","DOI":"10.1371\/journal.pone.0071634","article-title":"Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease","volume":"8","author":"Gardai","year":"2013","journal-title":"PLoS ONE"},{"key":"2021042500132194700_DMM028035C20","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1042\/BST0390984","article-title":"Plasma PLTP (phospholipid-transfer protein): an emerging role in \u2018reverse lipopolysaccharide transport\u2019 and innate immunity","volume":"39","author":"Gautier","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"2021042500132194700_DMM028035C21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/archneur.62.1.96","article-title":"Failure to find alpha-synuclein gene dosage changes in 190 patients with familial Parkinson disease","volume":"62","author":"Gispert","year":"2005","journal-title":"Arch. Neurol."},{"key":"2021042500132194700_DMM028035C22","doi-asserted-by":"publisher","first-page":"e5777","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PLoS ONE"},{"key":"2021042500132194700_DMM028035C23","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1093\/hmg\/ddt338","article-title":"Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors","volume":"22","author":"Gispert","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"2021042500132194700_DMM028035C24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12035-014-8844-0","article-title":"Complexin-1 and Foxp1 expression changes are novel brain effects of alpha-synuclein pathology","volume":"52","author":"Gispert","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"2021042500132194700_DMM028035C25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/hmg\/ddu520","article-title":"Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression","volume":"24","author":"Gispert","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"2021042500132194700_DMM028035C26","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/hmg\/ddi239","article-title":"Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficits","volume":"14","author":"Glynn","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"2021042500132194700_DMM028035C27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"2021042500132194700_DMM028035C28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.410270309","article-title":"A large kindred with autosomal dominant Parkinson's disease","volume":"27","author":"Golbe","year":"1990","journal-title":"Ann. Neurol."},{"key":"2021042500132194700_DMM028035C29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021042500132194700_DMM028035C30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.brainres.2006.08.036","article-title":"Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease","volume":"1118","author":"Iczkiewicz","year":"2006","journal-title":"Brain Res."},{"key":"2021042500132194700_DMM028035C31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","article-title":"Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study","volume":"12","author":"Iranzo","year":"2013","journal-title":"Lancet Neurol."},{"key":"2021042500132194700_DMM028035C32","doi-asserted-by":"publisher","first-page":"e89741","DOI":"10.1371\/journal.pone.0089741","article-title":"Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients","volume":"9","author":"Iranzo","year":"2014","journal-title":"PLoS ONE"},{"key":"2021042500132194700_DMM028035C33","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","article-title":"Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model","volume":"110","author":"Janezic","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042500132194700_DMM028035C34","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1096\/fj.04-1917fje","article-title":"Alpha-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease","volume":"18","author":"Kim","year":"2004","journal-title":"FASEB J."},{"key":"2021042500132194700_DMM028035C35","doi-asserted-by":"publisher","first-page":"e11464","DOI":"10.1371\/journal.pone.0011464","article-title":"A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice","volume":"5","author":"Kurz","year":"2010","journal-title":"PLoS ONE"},{"key":"2021042500132194700_DMM028035C36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/dnares\/5.6.401","article-title":"Absence of mutation in the beta- and gamma-synuclein genes in familial autosomal dominant Parkinson's disease","volume":"5","author":"Lavedan","year":"1998","journal-title":"DNA Res."},{"key":"2021042500132194700_DMM028035C37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"2021042500132194700_DMM028035C38","doi-asserted-by":"publisher","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","article-title":"Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database","volume":"8","author":"Lill","year":"2012","journal-title":"PLoS Genet."},{"key":"2021042500132194700_DMM028035C39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)). Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2021042500132194700_DMM028035C40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.nbd.2006.10.020","article-title":"Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model","volume":"25","author":"Maetzler","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"2021042500132194700_DMM028035C41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1474-4422(13)70078-4","article-title":"REM sleep behaviour disorder: a marker of synucleinopathy","volume":"12","author":"Mahowald","year":"2013","journal-title":"Lancet Neurol."},{"key":"2021042500132194700_DMM028035C42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson Progression Marker Initiative (PPMI)","volume":"95","author":"Marek","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"2021042500132194700_DMM028035C43","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1468-1331.2008.02154.x","article-title":"The prevalence of the G2019S and R1441C\/G\/H mutations in LRRK2 in German patients with Parkinson's disease","volume":"15","author":"M\u00f6ller","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"2021042500132194700_DMM028035C44","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat. Methods"},{"key":"2021042500132194700_DMM028035C45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/NEN.0b013e31827c5710","article-title":"Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies","volume":"72","author":"Mukaetova-Ladinska","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2021042500132194700_DMM028035C46","doi-asserted-by":"publisher","first-page":"E2079","DOI":"10.1002\/humu.21459","article-title":"SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes","volume":"32","author":"Mutez","year":"2011","journal-title":"Hum. Mutat."},{"key":"2021042500132194700_DMM028035C47","doi-asserted-by":"publisher","first-page":"17186","DOI":"10.1523\/JNEUROSCI.2220-12.2012","article-title":"Accumulation of alpha-synuclein triggered by presynaptic dysfunction","volume":"32","author":"Nakata","year":"2012","journal-title":"J. Neurosci."},{"key":"2021042500132194700_DMM028035C48","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"key":"2021042500132194700_DMM028035C49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"2021042500132194700_DMM028035C50","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.20753","article-title":"Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease","volume":"59","author":"Nishioka","year":"2006","journal-title":"Ann. Neurol."},{"key":"2021042500132194700_DMM028035C51","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1182\/blood.V100.7.2506","article-title":"Evidence that alpha-synuclein functions as a negative regulator of Ca(++)-dependent alpha-granule release from human platelets","volume":"100","author":"Park","year":"2002","journal-title":"Blood"},{"key":"2021042500132194700_DMM028035C52","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1523\/JNEUROSCI.3730-10.2011","article-title":"LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool","volume":"31","author":"Piccoli","year":"2011","journal-title":"J. Neurosci."},{"key":"2021042500132194700_DMM028035C53","doi-asserted-by":"publisher","first-page":"e36397","DOI":"10.1371\/journal.pone.0036397","article-title":"Striatal dopamine transmission is subtly modified in human A53Talpha-synuclein overexpressing mice","volume":"7","author":"Platt","year":"2012","journal-title":"PLoS ONE"},{"key":"2021042500132194700_DMM028035C54","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson's disease to chromosome 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"2021042500132194700_DMM028035C55","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"2021042500132194700_DMM028035C56","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","article-title":"Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov. Disord."},{"key":"2021042500132194700_DMM028035C57","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.thromres.2010.01.009","article-title":"Mice with deleted multimerin 1 and alpha-synuclein genes have impaired platelet adhesion and impaired thrombus formation that is corrected by multimerin 1","volume":"125","author":"Reheman","year":"2010","journal-title":"Thromb. Res."},{"key":"2021042500132194700_DMM028035C58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0092-8674(01)00192-1","article-title":"Complexins regulate a late step in Ca2+-dependent neurotransmitter release","volume":"104","author":"Reim","year":"2001","journal-title":"Cell"},{"key":"2021042500132194700_DMM028035C59","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ncomms2032","article-title":"Alternative alpha-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology","volume":"3","author":"Rhinn","year":"2012","journal-title":"Nat. Commun."},{"key":"2021042500132194700_DMM028035C60","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/mds.20245","article-title":"Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting \u201csleep attacks\u201d","volume":"19","author":"Rissling","year":"2004","journal-title":"Mov. Disord."},{"key":"2021042500132194700_DMM028035C61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2021042500132194700_DMM028035C62","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.1423573112","article-title":"Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease","volume":"112","author":"Santiago","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042500132194700_DMM028035C63","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1073\/pnas.0610204104","article-title":"Molecular markers of early Parkinson's disease based on gene expression in blood","volume":"104","author":"Scherzer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042500132194700_DMM028035C64","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00401-010-0717-7","article-title":"Axonal inclusions in spinocerebellar ataxia type 3","volume":"120","author":"Seidel","year":"2010","journal-title":"Acta Neuropathol."},{"key":"2021042500132194700_DMM028035C65","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ana.22078","article-title":"First appraisal of brain pathology owing to A30P mutant alpha-synuclein","volume":"67","author":"Seidel","year":"2010","journal-title":"Ann. Neurol."},{"key":"2021042500132194700_DMM028035C66","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"2021042500132194700_DMM028035C67","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1074\/mcp.m114.040576","article-title":"Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation","volume":"14","author":"Shi","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"2021042500132194700_DMM028035C68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10059-000-0065-x","article-title":"Expression patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages","volume":"10","author":"Shin","year":"2000","journal-title":"Mol. Cells"},{"key":"2021042500132194700_DMM028035C69","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"key":"2021042500132194700_DMM028035C70","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"2021042500132194700_DMM028035C71","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/brain\/awh322","article-title":"Combination of \u2018idiopathic\u2019 REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT","volume":"128","author":"Stiasny-Kolster","year":"2005","journal-title":"Brain"},{"key":"2021042500132194700_DMM028035C72","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042500132194700_DMM028035C73","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1093\/bioinformatics\/btm369","article-title":"GSEA-P: a desktop application for Gene Set Enrichment Analysis","volume":"23","author":"Subramanian","year":"2007","journal-title":"Bioinformatics"},{"key":"2021042500132194700_DMM028035C74","doi-asserted-by":"publisher","first-page":"13586","DOI":"10.1523\/JNEUROSCI.5069-13.2014","article-title":"Mutant alpha-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels","volume":"34","author":"Subramaniam","year":"2014","journal-title":"J. Neurosci."},{"key":"2021042500132194700_DMM028035C75","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2011.05.002","article-title":"Mechanisms underlying altered striatal synaptic plasticity in old A53T-alpha synuclein overexpressing mice","volume":"33","author":"Tozzi","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"2021042500132194700_DMM028035C76","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.nbd.2014.10.011","article-title":"Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous alpha-synuclein fibrils","volume":"73C","author":"Tsujimura","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"2021042500132194700_DMM028035C77","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocerebrosidase mutations and parkinsonism","volume":"17","author":"Westbroek","year":"2011","journal-title":"Trends Mol. Med."},{"key":"2021042500132194700_DMM028035C78","doi-asserted-by":"publisher","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","article-title":"Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases","volume":"286","author":"Yap","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021042500132194700_DMM028035C79","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2047-9158-2-16","article-title":"Neurodegenerative changes initiated by presynaptic dysfunction","volume":"2","author":"Yasuda","year":"2013","journal-title":"Transl. Neurodegener."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1242\/dmm.028035","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/10\/5\/619\/1860500\/dmm028035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.028035\/2069189\/dmm_028035v1.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.028035\/2069189\/dmm_028035v1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T22:04:18Z","timestamp":1621375458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/doi\/10.1242\/dmm.028035\/257057\/Blood-RNA-biomarkers-in-prodromal-PARK4-and-REM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":79,"URL":"https:\/\/doi.org\/10.1242\/dmm.028035","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,1]]},"article-number":"dmm.028035"}}